Abbott Laboratories Stock Advances 3.7%, Outperforms Competitors

Dow Jones03-27

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Abbott Laboratories rose 3.7% to $131.35 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.3% to 5,693.31 and Dow Jones Industrial Average falling 0.4% to 42,299.70.

This was the stock's second consecutive day of gains.

Abbott Laboratories closed 7.0% below its 52-week high of $141.23, which the company achieved on March 4th.

The stock outperformed some of its competitors, as Johnson & Johnson rose 0.9% to $163.13, Pfizer Inc. fell 0.8% to $25.01, and Merck & Co. Inc. fell 0.58% to $87.60.

Trading volume totaled 8.4 million, compared to the 50-day average of 7.1 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

March 27, 2025 16:34 ET (20:34 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2522053458?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-28 04:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522053458","market":"sg","top_or_hot":-1,"title":"Abbott Laboratories Stock Advances 3.7%, Outperforms Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Abbott Laboratories rose 3.7% to $131.35 on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index falling 0.3% to 5,693.31 and Dow Jones Industrial Average falling 0.4% to 42,299.70. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Abbott Laboratories closed 7.0% below its 52-week high of $141.23, which the company achieved on March 4th. \n</p>\n<p>\n     The stock outperformed some of its competitors, as Johnson &amp; Johnson rose 0.9% to $163.13, Pfizer Inc. fell 0.8% to $25.01, and Merck &amp; Co. Inc. fell 0.58% to $87.60. \n</p>\n<p>\n     Trading volume totaled 8.4 million, compared to the 50-day average of 7.1 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 27, 2025 16:34 ET (20:34 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Abbott Laboratories Stock Advances 3.7%, Outperforms Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAbbott Laboratories Stock Advances 3.7%, Outperforms Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-28 04:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Abbott Laboratories rose 3.7% to $131.35 on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index falling 0.3% to 5,693.31 and Dow Jones Industrial Average falling 0.4% to 42,299.70. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Abbott Laboratories closed 7.0% below its 52-week high of $141.23, which the company achieved on March 4th. \n</p>\n<p>\n     The stock outperformed some of its competitors, as Johnson &amp; Johnson rose 0.9% to $163.13, Pfizer Inc. fell 0.8% to $25.01, and Merck &amp; Co. Inc. fell 0.58% to $87.60. \n</p>\n<p>\n     Trading volume totaled 8.4 million, compared to the 50-day average of 7.1 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 27, 2025 16:34 ET (20:34 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2522053458","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522053458","pubTimestamp":1743107640,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Abbott Laboratories rose 3.7% to $131.35 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.3% to 5,693.31 and Dow Jones Industrial Average falling 0.4% to 42,299.70.This was the stock's second consecutive day of gains.Abbott Laboratories closed 7.0% below its 52-week high of $141.23, which the company achieved on March 4th.The stock outperformed some of its competitors, as Johnson & Johnson rose 0.9% to $163.13, Pfizer Inc. fell 0.8% to $25.01, and Merck & Co. Inc. fell 0.58% to $87.60.Trading volume totaled 8.4 million, compared to the 50-day average of 7.1 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"雅培实验室股价上涨3.7%，跑赢竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Abbott Laboratories rose 3.7% to $131.35 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.3% to 5,693.31 and Dow Jones Industrial Average falling 0.4% to 42,299.70. \n\n\n     This was the stock's second consecutive day of gains. \n\n\n     Abbott Laboratories closed 7.0% below its 52-week high of $141.23, which the company achieved on March 4th. \n\n\n     The stock outperformed some of its competitors, as Johnson & Johnson rose 0.9% to $163.13, Pfizer Inc. fell 0.8% to $25.01, and Merck & Co. Inc. fell 0.58% to $87.60. \n\n\n     Trading volume totaled 8.4 million, compared to the 50-day average of 7.1 million. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2025 16:34 ET (20:34 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2522053458"}